Hepatitis B Reactivation and Rituximab in the Oncology Practice
ONCOLOGIST (2010)
Journal
ONCOLOGIST
Volume 15, Issue 10, Pages 1113-1121Publisher
WILEY
Keywords
Categories
Ask authors/readers for more resources
Authors
I am an author on this paper
Reviews
Recommended
HBsAg (-)/HBsAb (-)/HBeAg (-)/HBeAb (+)/HBcAb (+) predicts a high risk of hepatitis B reactivation in patients with B-cell lymphoma receiving rituximab based immunochemotherapy
Li-Ping Shui, Yan Zhu, Xiao-Qin Duan, Yu-Ting Chen, Li Yang, Xiao-Qiong Tang, Hong-Bin Zhang, Qing Xiao, Li Wang, Lin Liu, Xiao-Hua Luo
JOURNAL OF MEDICAL VIROLOGY (2023)
A case report of hepatitis B virus reactivation 19 months after cessation of chemotherapy with rituximab
Xiangjuan Guo, Tongtong Ji, Shengliang Xin, Jinghang Xu, Yanyan Yu
FRONTIERS IN IMMUNOLOGY (2022)
Clinical and economic evaluation of a surveillance protocol to manage hepatitis B virus (HBV) reactivation among lymphoma patients with resolved HBV infection receiving rituximab
Chia Jie Tan, Rajneesh Kumar, Narendran Koomanan, Wei Sheng Loo, Mohamad Farid, Miriam Tao, Nagavalli Somasundaram, Eileen Poon, Jason Yongsheng Chan, Valerie Shiwen Yang, Esther Chang, Soon Thye Lim, Wan Cheng Chow, Alexandre Chan, Tiffany Tang
PHARMACOTHERAPY (2021)
High Risk of Viral Reactivation in Hepatitis B Patients with Systemic Lupus Erythematosus
Ming-Han Chen, Chien-Sheng Wu, Ming-Huang Chen, Chang-Youh Tsai, Fa-Yauh Lee, Yi-Hsiang Huang
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Management of Hepatitis B Virus Reactivation in Malignant Lymphoma Prior to Immunosuppressive Treatment
Yu-Fen Tsai, Chin-Mu Hsu, Hui-Hua Hsiao
JOURNAL OF PERSONALIZED MEDICINE (2021)
HBV Reactivation During the Treatment of Non-Hodgkin Lymphoma and Management Strategies
Xing Cao, Yafei Wang, Panyun Li, Wei Huang, Xiaojuan Lu, Hongda Lu
FRONTIERS IN ONCOLOGY (2021)
Resolved hepatitis B infection in patients receiving immunosuppressive therapy: Monitor versus prophylaxis against viral reactivation
Mohamed A. Elsebaey, Tamer A. Elbedewy, Heba Elashry, Waleed Elrefaey, Samah A. Elshweikh, Ahmed A. Elhadidy, Neveen A. Shalaby, Assem Mohamed Elsokkary, Hossam Eldin A. Elashtokhy, Yousry Esam-Eldin Abo-Amer, Ashraf Rafat Abo-Elfetoh, Sharaf Elsayed Ali Hassanien, Amina Fouad, Raghda Samir Abdellatif, Amro Abdelaziz Mohammed Ismail
MEDICINE (2022)
Stratified management based on surface antibody for the prevention of hepatitis B virus reactivation in lymphoma patients
Hailing Liu, Zhen He, Renfu Gui, Jingjing Guo, Lvwen Chen, Miao Zhong, Jianyong Li, Lei Cao, Lei Fan
BRITISH JOURNAL OF HAEMATOLOGY (2023)
Mantle-Cell Lymphoma
Leonid L. Yavorkovsky
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Hepatitis B reactivation is a rare event among patients with resolved infection undergoing anti-CD20 antibodies in monotherapy without antiviral prophylaxis: results from the HEBEM study
Blanca Marzo, Angela Vidal-Jordana, Joaquin Castillo, Miguel-Angel Robles-Sanchez, Susana Otero-Romero, Mar Tintore, Xavier Montalban, Maria Buti, Mar Riveiro-Barciela
JOURNAL OF NEUROLOGY (2023)
Treated chronic hepatitis B is a good prognostic factor of diffuse large B-cell lymphoma
Jeayeon Park, Sung Won Chung, Yun Bin Lee, Hyunjae Shin, Moon Haeng Hur, Heejin Cho, Min Kyung Park, Jeonghwan Youk, Ji Yun Lee, Jeong-Ok Lee, Su Jong Yu, Yoon Jun Kim, Jung-Hwan Yoon, Tae Min Kim, Jeong-Hoon Lee
CLINICAL AND MOLECULAR HEPATOLOGY (2023)
Immune predictors of hepatitis B surface antigen seroconversion in patients with hepatitis B reactivation
Mojahidul Islam, Jayesh Kumar Sevak, Manoj Kumar Sharma, Ankur Jindal, Ashish Kumar Vyas, Meenu Bajpai, Gayatri Ramakrishna, Shiv Kumar Sarin, Nirupma Trehanpati
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2023)
The Low Incidence of Viral Hepatitis Reactivation Among Subjects on Immunotherapy Reduces the Impact of Suboptimal Screening Rate
Laia Aceituno, Juan Banares, Lourdes Ruiz-Ortega, Ana Callejo-Perez, Eva Munoz-Couselo, Carolina Ortiz-Velez, Nely Diaz-Mejia, Ana Barreira-Diaz, Maria Jose Carreras, Anna Farriols, Maria Buti, Mar Riveiro-Barciela
FRONTIERS IN MEDICINE (2022)
Reactivation of Resolved Hepatitis B After Daratumumab for Multiple Myeloma
Soon Kyu Lee, Pil Soo Sung, Sung-Soo Park, Chang-Ki Min, Heechul Nam, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon
CLINICAL INFECTIOUS DISEASES (2021)
Hepatitis B Virus Reactivation 55 Months Following Chemotherapy Including Rituximab and Autologous Peripheral Blood Stem Cell Transplantation for Malignant Lymphoma
Tasuku Hara, Kohei Oka, Naoto Iwai, Yutaka Inada, Toshifumi Tsuji, Takashi Okuda, Akihiro Nagata, Toshiyuki Komaki, Keizo Kagawa
INTERNAL MEDICINE (2021)
Impact of Institutional Universal Microsatellite-Instability (MSI) Reflex Testing on Molecular Profiling Differences Between Younger and Older Patients with Colorectal Cancer
Ellery Altshuler, Aaron J. Franke, William Paul Skelton, Michael Feely, Yu Wang, Ji-Hyun Lee, Thomas Read, Krista Terracina, Xiang -Yang Lou, Yunfeng Dai, Thomas J. George
CLINICAL COLORECTAL CANCER (2023)
Multicenter Phase II Trial of the WEE1 Inhibitor Adavosertib in Refractory Solid Tumors Harboring CCNE1 Amplification
Siqing Fu, Shuyang Yao, Yuan Yuan, Rebecca A. Previs, Anthony D. Elias, Richard D. Carvajal, Thomas J. George, Ying Yuan, Lihou Yu, Shannon N. Westin, Yan Xing, Ecaterina E. Dumbrava, Daniel D. Karp, Sarina A. Piha-Paul, Apostolia M. Tsimberidou, Jordi Rodon Ahnert, Naoko Takebe, Karen Lu, Khandan Keyomarsi, Funda Meric-Bernstam
JOURNAL OF CLINICAL ONCOLOGY (2023)
Validation of a pelvic surgery difficulty risk model to predict difficult pelvic dissection and poor outcomes
Atif Iqbal, Aimal Khan, Steven Hughes, Sanda Tan, Hector Garcia-Chavez, Thomas J. George, Thomas Read
SURGERY (2023)
Cancer incidence after asthma diagnosis: Evidence from a large clinical research network in the United States
Yi Guo, Jiang Bian, Zhaoyi Chen, Jennifer N. N. Fishe, Dongyu Zhang, Dejana Braithwaite, Thomas J. J. George, Elizabeth A. A. Shenkman, Jonathan D. D. Licht
CANCER MEDICINE (2023)
A nurse-led intervention in patients with newly diagnosed cancer and Type 2 diabetes: A pilot randomized controlled trial feasibility study
Lisa Scarton, Tarah Nelson, Ara Jo, LaToya J. O'Neal, Yingwei Yao, Shavondra Huggins, Anatolia B. Legaspi, Mariah J. McClaren, Jake S. Cabassa, Joan Burgos M. Melendez, Juan M. Munoz-Pena, Merry J. Markham, Martina C. Murphy, Jonathan A. Chatzkel, Sherise Rogers, Thomas J. George
CANCER MEDICINE (2023)
Fertility Preservation Knowledge, Attitudes, and Self-Reported Behaviors of Resident Physicians
Vasanti Jhaveri, Celeste G. Yergin, Alexis Jennings, Jessica Heft, Merry J. Markham, Alice Rhoton-Vlasak
JOURNAL OF ADOLESCENT AND YOUNG ADULT ONCOLOGY (2023)
Impact of the Immediate Release of Clinical Information Rules on Health Care Delivery to Patients With Cancer
P. Abena Anyidoho, Claire F. Verschraegen, Merry Jennifer Markham, Steven Alberts, John Sweetenham, Kendra Cameron, Taher Abu Hejleh
JCO ONCOLOGY PRACTICE (2023)
Call to action: overcoming enrollment disparities in cancer clinical trials with modernized eligibility criteria
Andrea N. Riner, Devon C. Freudenberger, Kelly M. Herremans, Vignesh Vudatha, Daniel W. Neal, Thomas J. George, Jose G. Trevino
JNCI CANCER SPECTRUM (2023)
National adoption of neoadjuvant chemotherapy: paradigm shift in the treatment of pancreatic cancer
Ibrahim Nassour, Austin Parrish, Lucy Baptist, Sarah Voskamp, Komal Handoo, Sherise Rogers, Jesus Fabregas, Thomas George, Kathryn Hitchcock, Alessandro Paniccia, Steven Hughes
HPB (2023)
Prognosis and Treatment Outcomes of Bone Metastasis in Gallbladder Adenocarcinoma: A SEER-Based Study
Kriti Gera, Doga Kahramangil, Graeme A. Fenton, Daniela Martir, Diana N. Rodriguez, Zohaib Ijaz, Rick Y. Lin, Sherise C. Rogers, Brian H. Ramnaraign, Thomas J. George, Young-Rock Hong, Steven J. Hughes, Ibrahim Nassour, Ilyas Sahin
CANCERS (2023)
Effects of Clinical and Tumor Characteristics on Survival in Patients with Hepatocellular Carcinoma with Bone Metastasis
Muhammet Ozer, Suleyman Yasin Goksu, Rick Y. Lin, Ruveyda Ayasun, Doga Kahramangil, Sherise C. Rogers, Jesus C. Fabregas, Brian H. Ramnaraign, Thomas J. George, Michael Feely, Roniel Cabrera, Sergio Duarte, Ali Zarrinpar, Ilyas Sahin
JOURNAL OF HEPATOCELLULAR CARCINOMA (2023)
Gold Nanoparticle-Based Microfluidic Chips for Capture and Detection of Circulating Tumor Cells
Valber A. Pedrosa, Kangfu Chen, Thomas J. George, Z. Hugh Fan
BIOSENSORS-BASEL (2023)
Ethical Considerations of Biopsies in Early-Stage Pancreatic Cancer
Riley P. Bohan, Andrea N. Riner, Kelly M. Herremans, Thomas J. George, Steven J. Hughes, Lauren B. Solberg
JCO ONCOLOGY PRACTICE (2023)
Quantifying the impact of the COVID-19 pandemic on cancer center clinical trial operations
Thomas J. George, Tara L. Lin, Tricia Adrales Bentz, Stefan Grant, Collette M. Houston, Melissa A. Nashawati, Bhanu Pappu, Helen Peck, Alex Zafirovski, Kimberly Kerstann, Patricia Lorusso, Anne Schnatterly, Janie Hofacker, Kendra Cameron, Hailey Honeycutt, Theresa L. Werner
JNCI CANCER SPECTRUM (2023)
Feasibility metric outcomes: A nurse-led intervention to identify and manage undiagnosed type 2 diabetes in patients with newly diagnosed cancer
Lisa Scarton, Tarah Nelson, Yingwei Yao, Shavondra Huggins, Ara Jo, LaToya J. O'Neal, Thomas J. George, Juan M. Munoz-Pena, Merry J. Markham, Martina C. Murphy, Jonathan A. Chatzkel, Sherise Rogers
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2023)